EUVIMEDEUVIMED entdecken
Fallbericht

Antineurofascin IgG2 ‐associated paediatric autoimmune nodopathy

Rachel E Harris, Mark Atherton iD, Johann Te Water Naude, Georgina A Bird-Lieberman, Sithara Ramdas iD, Janev Fehmi, Simon Rinaldi, Min T Ong

Developmental Medicine & Child Neurology · 2023-08 · 65 (8) · 1118-1122

DOI: 10.1111/dmcn.15493 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 11.01.2023. Verfasst von Rachel E Harris und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Neurology, Sheffield Children's Hospital, Sheffield, UK. Hauptthemen laut MEDLINE: Immunoglobulin G, Immunoglobulins, Intravenous. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this case series of four paediatric patients, we present the first described cases of immunotherapy‐responsive autoimmune nodopathy with IgG2 antineurofascin antibodies. In three cases, the antineurofascin antibodies were predominantly of the IgG2 subclass, a novel finding in comparison to previously described adult cases where IgG4 and/or IgG1/3 have typically been described. One patient had low signal for IgG2 with predominant IgG1 and IgG4 antibodies, a pattern commonly seen in adult patients. Two patients had antibodies targeting all three neurofascin isoforms (155, 186, and 140), whereas antibodies in the sera from the third targeted only the nodal isoforms 186 and 140, and the fourth patient only neurofascin 155. The three patients with IgG2 predominant antibodies appear to be responsive to intravenous immunoglobulin (IVIG) to varying degrees thus far, whereas the patient with IgG1/4 antibodies had poor response to IVIG but good response to steroids. Although the full clinical significance of IgG2 predominant antineurofascin antibodies in the context of childhood polyneuropathy remains unclear, emerging evidence of serological‐phenotypic correlation may inform prognostication and therapeutic decision‐making, warranting further study into this area. What this paper adds Paediatric immunotherapy‐responsive nodopathies were associated with antineurofascin antibodies predominantly of the IgG2 subclass in 3 out of 4 patients. Identification of antibodies and understanding their phenotypic relevance could predict response to treatment and guide therapeutic decision‐making in children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin GImmunoglobulins, IntravenousAdultHumansChild

Substanzen

Immunoglobulin GImmunoglobulins, Intravenous

Autor:innen und Institutionen

  • Department of Paediatric Neurology, Sheffield Children's Hospital, Sheffield, UK.
  • Department of Paediatric Neurology, University Hospital of Wales, Cardiff, UK.
  • Department of Paediatric Neurology, Southampton Children's Hospital, Southampton, UK.
  • Department of Paediatric Neurology, John Radcliffe Hospital, Oxford, UK.
  • MDUK Neuromuscular Centre, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

ORCID-Profile: Mark Atherton, Sithara Ramdas

Förderung

  • Medical Research Council

Zitieren

APA

Harris, R. E., Atherton, M., Naude, J. T. W., Bird-Lieberman, G. A., Ramdas, S., Fehmi, J., Rinaldi, S., & Ong, M. T. (2023). Antineurofascin IgG2 ‐associated paediatric autoimmune nodopathy. Developmental Medicine & Child Neurology, 65(8), 1118-1122. https://doi.org/10.1111/dmcn.15493

Vancouver

Harris RE, Atherton M, Naude JTW, Bird-Lieberman GA, Ramdas S, Fehmi J, et al. Antineurofascin IgG2 ‐associated paediatric autoimmune nodopathy. Developmental Medicine & Child Neurology. 2023;65(8):1118-1122. doi:10.1111/dmcn.15493

BibTeX
@article{Harris2023,
  author = {Harris, Rachel E and Atherton, Mark and Naude, Johann Te Water and Bird-Lieberman, Georgina A and Ramdas, Sithara and Fehmi, Janev and Rinaldi, Simon and Ong, Min T},
  title = {Antineurofascin IgG2 ‐associated paediatric autoimmune nodopathy},
  journal = {Developmental Medicine & Child Neurology},
  year = {2023},
  volume = {65},
  number = {8},
  pages = {1118--1122},
  doi = {10.1111/dmcn.15493}
}
Kostenlos starten →